A total of (90) blood samples were collected from male patients infected with Toxoplasmosis who recovered from COVID- 19 and attended Kamal Alsamiraai Hospital from 15 January to 15 September 2021. We measured anti-Toxoplasma antibodies (IgG and IgM) detected by ELISA, whereas Anti-COVID-19 antibodies (IgG and IgM) were estimated using Elisa and Afilias. The semen characteristics were also studied among fertile, healthy individuals (control group) and sub-fertile patients. Results showed that the mean sperm count was high among the control group (40.5±1.3x 106/ml) compared with that of the sub-fertile patients (10.3±1.75 and 8.8±1.9 x 106/ml for oligozoospermia, and oligoasthenozoospermia respectively), and it was the highest (44.7±1.4 x 106/ml) among asthenozoospermia patients. Compared to the control group, there were highly significant differences between anti-Toxoplasma IgG antibodies and anti-COVID-19 IgG antibodies (P<0.001). The mean level of Toxoplasma IgM was (11.74±8.90) and for control was (0.05±0.10), while the mean level of COVID-19 IgM was (1.91±1.06) and for control was (0.04±0.03) in sub-fertile patients. The mutation occurred in IL-IB gene A to G transgene at site 4514 of the IL-IB gene (sample code, 6383) and in the case of an invalid sample code, 2409 and 5097. In the alanine codon, the GCA codon has mutated into GCG. Also, G to A transgene occurred at site 4514 of the IL-IB gene. (sample code, 6750) In the case of an invalid sample code, it happened in 010081 and 009593. In the alanine codon, the ATG codon has mutated into ATA.